🔎 Trials Near Me

Home › Plasma Cell Cancer

Plasma Cell Cancer clinical trials recruiting in the U.S.

24 studies for Plasma Cell Cancer are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Rutgers University Study of the Genetics of Blood Cancers

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 110 · All sexes · Updated Sep 25, 2026 · NCT07714044

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04879043

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 80 · All sexes · Updated Sep 1, 2026 · NCT00106925

Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma

RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Aug 20, 2026 · NCT06066359

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT05651932

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07426484

Delayed Toxicities Post-CAR-T

RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07665307

Pre-malignant States to Hematologic Malignancies in Firefighters

RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 49 · All sexes · Updated Jul 13, 2026 · NCT06870760

Registry of Older Patients With Cancer

RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825

High Dose Ascorbic Acid (HDAA) in Patients With Plasma Cell Disorders

RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Jun 4, 2026 · NCT06313502

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated May 26, 2026 · NCT07052916

Pilot Imaging Study of Leukemia

RecruitingPhase 1
Ages 4 to 80 · All sexes · Updated Apr 23, 2026 · NCT03633955

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Recruiting
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT05745285

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

Recruiting
Ages 21 and older · All sexes · Updated Feb 5, 2026 · NCT07390071

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT06518551

Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 3, 2025 · NCT06947083

Subcutaneous Daratumumab Administration in the Thigh Vs Abdomen in Plasma Cell Disorders

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 29, 2025 · NCT07075510

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643

HEME Home Transfusion Program

Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2025 · NCT06487247

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 10, 2025 · NCT05597345

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Aug 2, 2024 · NCT06271252

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.